In addition to TRPC5, both gain-of-function (22, 23) and loss-of-function mutations in TRPC6 channel activity contribute to podocyte injury (24), further implicating TRPC channel activity in chronic kidney diseases. Here, TRPC5 is linked to chronic kidney disease.